We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
-18.72%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$79.5M
AUM Growth
-$124M
Cap. Flow
-$105M
Cap. Flow %
-132.59%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$695K

Top Sells

Rank Stock Value
1
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
1
Collegium Pharmaceutical
COLL
$820M
$29.4M 36.98%
1,887,332
– –
IOVA icon
2
Iovance Biotherapeutics
IOVA
$3.74B
$15.2M 19.14%
2,188,331
+101,050
+5% +$695K
CDTX
3
DELISTED
Cidara Therapeutics
CDTX
$13.6M 17.18%
65,613
– –
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$12.9M 16.26%
2,600,014
– –
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$5.04M 6.34%
950,366
– –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.26M 4.1%
54,655
– –
TBRA
7
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
– –
-2,668,570
Closed -$106M

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q4 2016 Portfolio in Review

As of Q4 2016, Frazier Management held 7 positions worth $79.5M, down 61% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management withdrew a net $105M in Q4 2016, closing 1 position. Its most notable exit was Tobira Therapeutics, Inc. Common Stock, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Frazier Management added an estimated $695K to Iovance Biotherapeutics.

  • Frazier Management added most to Iovance Biotherapeutics in Q4 2016, an estimated $695K increase.
  • Frazier Management fully exited Tobira Therapeutics, Inc. Common Stock in Q4 2016, selling an estimated $106M.
  • Frazier Management's ten largest holdings make up 100% of its $79.5M portfolio in Q4 2016.
  • Frazier Management opened 0 new positions and closed 1 in Q4 2016.
  • Frazier Management's portfolio value fell 61% quarter-over-quarter to $79.5M.

Based on Frazier Management's 13F filing for Q4 2016, filed 13 Feb 2017.